Condom use in prevention of human papillomavirus infections and cervical neoplasia: Systematic review of longitudinal studies

Journal of Medical Screening

Volumn 21, Issue 1, 2014, Pages 38-50

  Lam, Janni Uyen Hoa ^a   Rebolj, Matejka ^a   Dugué, Pierre Antoine ^a   Bonde, Jesper ^b   von Euler Chelpin, My ^a   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Cervical cancer; Cervical neoplasia; Condom; Human papillomavirus; Infection; Prevention

Indexed keywords

CERVICAL NEOPLASIA; COLPOSCOPY; CONDOM; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFECTION; LONGITUDINAL STUDY; MALE; MASS SCREENING; METHODOLOGY; PAPILLOMAVIRUS INFECTION; PREVENTION; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; WART VIRUS;

CERVICAL CANCER; CERVICAL NEOPLASIA; CONDOM; HUMAN PAPILLOMAVIRUS; INFECTION; PREVENTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CONDOMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84901297760     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141314522454     Document Type: Review

References (43)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1): 12-19.
2. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10(4): 321-322.
3. Rebolj M, Helmerhorst T, Habbema D, et al. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ 2012;345:e6855.
4. Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 2007;45(2-3): 93-106.
5. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002;29(11): 725-735.
6. CDC. Report to Congress: Prevention of Genital Human Papillomavirus Infection. URL: http://www.cdc.gov/std/HPV/2004HPV%20Report.pdf. Last accessed: 29 June 2013.
7. Morris K. FDA plans warning labels for condoms. Lancet Infect Dis 2004;4(5): 257.
8. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003;107(5): 811-816.
9. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354(25): 2645-2654.
10. Thomas I, Wright G, Ward B. The effect of condom use on cervical intraepithelial neoplasia grade I (CIN I). Aust N Z J Obstet Gynaecol 1990;30(3): 236-239.
11. Sanchez-Aleman MA, Uribe-Salas FJ, Lazcano-Ponce EC, Conde-Glez CJ. Human papillomavirus incidence and risk factors among Mexican female college students. Sex Transm Dis 2011;38(4): 275-278.
12. Shew ML, Fortenberry JD, Tu W, et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papilloma-virus infection among adolescent women. Arch Pediatr Adolesc Med 2006;160(2): 151-156.
13. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285(23): 2995-3002.
14. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338(7): 423-428.
15. Munk AC, Gudlaugsson E, Ovestad IT, et al. Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression. Gynecol Oncol 2012;127(3): 489-494.
16. Munk AC, Gudlaugsson E, Malpica A, et al. Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3. PLoS One 2012;7(9): e45114.
17. Munk AC, Ovestad IT, Gudlaugsson E, et al. Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study. Infect Agent Cancer 2012;7(1): 30.
18. Lytle CD, Routson LB, Seaborn GB, Dixon LG, Bushar HF, Cyr WH. An in vitro evaluation of condoms as barriers to a small virus. Sex Transm Dis 1997;24(3): 161-164.
19. Frega A, Cenci M, Stentella P, et al. Human papillomavirus in virgins and behaviour at risk. Cancer Lett 2003;194(1): 21-24.
20. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157(3): 218-226.
21. Poljak M, Kocjan BJ, Potocnik M, Seme K. Anogenital hairs are an important reservoir of alpha-papillomaviruses in patients with genital warts. J Infect Dis 2009;199(9): 1270-1274.
22. Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR. Condom use errors and problems: a global view. Sex Health 2012;9(1): 81-95.
23. Crosby R, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002;78(4): 228-231.
24. Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol 2003;69(1): 118-121.
25. Nielsen A, Iftner T, Munk C, Kjaer SK. Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis 2009;36(10): 609-615.
26. Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004;159(3): 242-251.
27. Peterman TA, Lin LS, Newman DR, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis 2000;27(8): 446-451.
28. Crosby R, Bounse S. Condom effectiveness: where are we now? Sex Health 2012;9(1): 10-17.
29. Macaluso M, Demand MJ, Artz LM, Hook III EW. Partner type and condom use. AIDS 2000;14(5): 537-546.
30. McCallum EB, Peterson ZD. Investigating the impact of inquiry mode on self-reported sexual behavior: theoretical considerations and review of the literature. J Sex Res 2012;49(2-3): 212-226.
31. Fenton KA, Johnson AM, McManus S, Erens B. Measuring sexual behaviour: methodological challenges in survey research. Sex Transm Infect 2001;77(2): 84-92.
32. Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med 2003;26(2): 104-123.
33. Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav 2006;35(3): 327-345.
34. Baer A, Saroiu S, Koutsky LA. Obtaining sensitive data through the Web: an example of design and methods. Epidemiology 2002;13(6): 640-645.
35. Wilson DP. Interpreting sexually transmissible infection prevention trials by adjusting for the magnitude of exposure. Clin Trials 2010;7(1): 36-43.
36. Grand Challenges in Global Health. Develop the Next Generation of Condom. URL: http://www.grandchallenges.org/Explorations/Topics/Pages/NextGenerationCondom Round11.aspx. Last accessed: 7 July 2013.
37. IARC. IARC Handbooks of Cancer Prevention, Vol. 10: Cervix cancer screening. International Agency for Research on cancer Press: Lyon, 2005.
38. Ronco G, Dillner J, Elfstrom KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2013 (Epub ahead of print).
39. Rebolj M, Njor SH, Lynge E. Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur J Cancer Prev 2012;21(1): 73-81.
40. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284.
41. Preisler S, Rebolj M, Untermann A, et al. Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay. PLoS One 2013;8(3): e59765.
42. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9(5): 425-434.
43. Soutter WP, de Barros LA, Fletcher A, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349(9057): 978-980.